Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-01-01 @ 4:13 PM
Study NCT ID:
NCT06041568
Status:
TERMINATED
Last Update Posted:
2025-02-10
First Post:
2023-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Imvotamab in Severe Systemic Lupus Erythematosus
Sponsor:
IGM Biosciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-11
First Submit QC Date:
None
Study First Post Date:
2023-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-06
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL